Scientists just created an artificial womb, which was successful in growing a premature lamb for up to four weeks. After the success of the animal trials, researchers are hoping to continue to advance the technology to create an artificial environment in which a premature human baby could survive.
The experiment required lamb fetuses, which are physiological similar to human fetuses, to be prematurely removed from their mother's womb via C-section, and placed in the sealed bio-bags for four to six weeks. All of the lambs developed at a healthy and normal rate.
Premature births are the leading cause of deaths among infants in North America, with about 30 000 annually, and a survival rate of only 50%. The sterile and sealed 'bio-bags,' which are filled with water and salts, closely resemble the womb of a human, and could save thousands of lives yearly.
Key Themes Behind This Trend
- Artificial Womb Technology
- The successful incubation of premature lambs in an artificial womb opens the door for the development of technology to incubate premature human babies and revolutionize neonatal care.
- Bio-mimicry in Medical Technology
- The development of a sealed 'bio-bag' that simulates the environment of a womb has the potential to inspire the creation of other medical technologies that mimic natural biological processes.
- Perinatal Health Innovation
- The artificial womb has the potential to transform perinatal healthcare by decreasing premature births, increasing survival rates, and providing new options for neonatal care.
Where This Applies
- Medical Devices and Equipment
- The development of an artificial womb and associated equipment provides new opportunities for medical device and equipment companies to create more effective and innovative neonatal care devices.
- Biotechnology
- The creation of an artificial environment in which a premature baby can develop provides an opportunity for biotechnology companies to develop new products that simulate natural biological processes.
- Healthcare Services
- The success of the artificial womb experiment could potentially lead to increased demand for neonatal healthcare services and a focus on advancing perinatal care in the healthcare industry.
